Follow
David R Cameron
David R Cameron
Debiopharm
Verified email at debiopharm.com
Title
Cited by
Cited by
Year
Whole genome characterization of the mechanisms of daptomycin resistance in clinical and laboratory derived isolates of Staphylococcus aureus
AY Peleg, S Miyakis, DV Ward, AM Earl, A Rubio, DR Cameron, S Pillai, ...
PloS one 7 (1), e28316, 2012
2582012
Serine/Threonine Phosphatase Stp1 Contributes to Reduced Susceptibility to Vancomycin and Virulence in Staphylococcus aureus
DR Cameron, DV Ward, X Kostoulias, BP Howden, RC Moellering Jr, ...
The Journal of infectious diseases 205 (11), 1677-1687, 2012
1132012
The Interface Between Antibiotic Resistance and Virulence in Staphylococcus aureus and Its Impact Upon Clinical Outcomes
DR Cameron, BP Howden, AY Peleg
Clinical infectious diseases 53 (6), 576-582, 2011
1072011
The RpoB H481Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus
W Gao, DR Cameron, JK Davies, X Kostoulias, J Stepnell, KL Tuck, ...
The Journal of infectious diseases 207 (6), 929-939, 2013
972013
Identification of a class of protein ADP-ribosylating sirtuins in microbial pathogens
JGM Rack, R Morra, E Barkauskaite, R Kraehenbuehl, A Ariza, Y Qu, ...
Molecular cell 59 (2), 309-320, 2015
932015
Antibiotic resistance and host immune evasion in Staphylococcus aureus mediated by a metabolic adaptation
JH Jiang, MS Bhuiyan, HH Shen, DR Cameron, TWT Rupasinghe, ...
Proceedings of the National Academy of Sciences 116 (9), 3722-3727, 2019
842019
A genetic determinant of persister cell formation in bacterial pathogens
DR Cameron, Y Shan, EA Zalis, V Isabella, K Lewis
Journal of bacteriology 200 (17), 10.1128/jb. 00303-18, 2018
782018
Stepwise Decrease in Daptomycin Susceptibility in Clinical Staphylococcus aureus Isolates Associated with an Initial Mutation in rpoB and a Compensatory Inactivation of the …
KT Bæk, L Thøgersen, RG Mogenssen, M Mellergaard, LE Thomsen, ...
Antimicrobial agents and chemotherapy 59 (11), 6983-6991, 2015
752015
Bacterial persisters in long-term infection: Emergence and fitness in a complex host environment
JA Bartell, DR Cameron, B Mojsoska, JAJ Haagensen, T Pressler, ...
PLoS pathogens 16 (12), e1009112, 2020
722020
Bacteriophages Improve Outcomes in Experimental Staphylococcus aureus Ventilator-associated Pneumonia
J Prazak, M Iten, DR Cameron, J Save, D Grandgirard, G Resch, ...
American journal of respiratory and critical care medicine 200 (9), 1126-1133, 2019
692019
Insights on virulence from the complete genome of Staphylococcus capitis
DR Cameron, JH Jiang, KA Hassan, LDH Elbourne, KL Tuck, IT Paulsen, ...
Frontiers in microbiology 6, 980, 2015
682015
Vancomycin susceptibility in methicillin-resistant Staphylococcus aureus is mediated by YycHI activation of the WalRK essential two-component regulatory system
DR Cameron, JH Jiang, X Kostoulias, DJ Foxwell, AY Peleg
Scientific reports 6 (1), 30823, 2016
562016
Structural Basis for Linezolid Binding Site Rearrangement in the Staphylococcus aureus Ribosome
MJ Belousoff, Z Eyal, M Radjainia, T Ahmed, RS Bamert, D Matzov, ...
MBio 8 (3), 10.1128/mbio. 00395-17, 2017
50*2017
Antibiotic regimen based on population analysis of residing persister cells eradicates Staphylococcus epidermidis biofilms
S Yang, ID Hay, DR Cameron, M Speir, B Cui, F Su, AY Peleg, T Lithgow, ...
Scientific Reports 5 (1), 18578, 2015
422015
Impact of daptomycin resistance on Staphylococcus aureus virulence
DR Cameron, LI Mortin, A Rubio, E Mylonakis, RC Moellering Jr, ...
Virulence 6 (2), 127-131, 2015
422015
Evolution of daptomycin resistance in coagulase-negative staphylococci involves mutations of the essential two-component regulator WalKR
JH Jiang, C Dexter, DR Cameron, IR Monk, SL Baines, IJ Abbott, ...
Antimicrobial agents and chemotherapy 63 (3), 10.1128/aac. 01926-18, 2019
352019
Benefits of Aerosolized Phages for the Treatment of Pneumonia Due to Methicillin-Resistant Staphylococcus aureus: An Experimental Study in Rats
J Prazak, LG Valente, M Iten, L Federer, D Grandgirard, S Soto, G Resch, ...
The journal of infectious diseases 225 (8), 1452-1459, 2022
312022
Nebulized bacteriophages for prophylaxis of experimental ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus
J Prazak, L Valente, M Iten, D Grandgirard, SL Leib, SM Jakob, ...
Critical care medicine 48 (7), 1042-1046, 2020
302020
Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors
DR Cameron, YH Lin, S Trouillet-Assant, V Tafani, X Kostoulias, ...
Clinical Microbiology and Infection 23 (10), 767-773, 2017
282017
Targeting NLRP3 and Staphylococcal pore-forming toxin receptors in human-induced pluripotent stem cell-derived macrophages
SH Chow, P Deo, ATY Yeung, XP Kostoulias, Y Jeon, ML Gao, A Seidi, ...
Journal of Leucocyte Biology 108 (3), 967-981, 2020
262020
The system can't perform the operation now. Try again later.
Articles 1–20